| P2093 | author name string | Hong Liu | |
| | Fang Wang | |
| | Yong Xie | |
| | Li-Wu Fu | |
| | Yi-Fan Chen | |
| | Xiao-Qin Zhao | |
| | Xiao-Kun Wang | |
| | Yan-Yan Yan | |
| P2860 | cites work | Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters | Q24617999 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | The human ATP-binding cassette (ABC) transporter superfamily | Q28204495 |
| | Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function | Q28475378 |
| | Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. | Q33194953 |
| | Emodin azide methyl anthraquinone derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage | Q33345153 |
| | A role for P-glycoprotein in regulating cell death | Q33918906 |
| | Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2. | Q34253081 |
| | Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction | Q34789068 |
| | P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance | Q35033926 |
| | P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells | Q35045233 |
| | Strategies for reversing drug resistance | Q35567287 |
| | Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo. | Q36057369 |
| | Mechanism of multidrug resistance in relation to passive membrane permeation | Q36082251 |
| | Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein | Q36166672 |
| | Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 |
| | Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) | Q36717554 |
| | The dihydro-beta-agarofuran sesquiterpenoids | Q36953218 |
| | Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 | Q37119716 |
| | Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential | Q37178982 |
| | Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells | Q39418811 |
| | Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu | Q39495900 |
| | Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol | Q44603146 |
| | Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria | Q46644453 |
| | HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance | Q57272492 |
| | P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death | Q57272499 |
| P433 | issue | 1 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 31-40 | |
| P577 | publication date | 2016-11-08 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro | |
| P478 | volume | 37 | |